Mevastatin-induced neurite outgrowth of neuroblastoma cells via activation of EGFR

Journal of Neuroscience Research

Volumn 87, Issue 9, 2009, Pages 2138-2144

  Evangelopoulos, M E ^a,c   Weis, J ^a,b,c   Kruttgen A ^a,b,c  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

NGF; Rab5; Rab7; Rap1

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; COMPACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEURON SPECIFIC NUCLEAR PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; RAB PROTEIN; RAB7 PROTEIN; RAP1 PROTEIN;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NERVE FIBER GROWTH; NEUROBLASTOMA CELL; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UPREGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL DIFFERENTIATION; CELL LINE, TUMOR; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LOVASTATIN; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MONOMERIC GTP-BINDING PROTEINS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURITES; NEUROGENESIS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN PRENYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION;

EID: 65849407988     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.22025     Document Type: Article

References (40)

1. Anger T, El-Chafchak J, Habib A, Stumpf C, Weyand M, Daniel WG, Hombach V, Hoeher M, Garlichs CD. 2008. Statins stimulate RGS-regulated ERK 1/2 activation in human calcified and stenotic aortic valves. Exp Mol Pathol. 85:101-111.
2. Brodeur GM. 2003. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 3:203-216.
3. Bronfman FC, Escudero CA, Weis J, Kruttgen A. 2007. Endosomal transport of neurotrophins: roles in signaling and neurodegenerative diseases. Dev Neurobiol 67:1183-1203.
4. Chan KK, Oza AM, Siu LL. 2003. The statins as anticancer agents. Clin Cancer Res 9:10-19.
5. Chen X, Resh MD. 2002. Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem 277:49631-49637.
6. Edsjo A, Holmquist L, Pahlman S. 2007. Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation. Semin Cancer Biol 17:248-256.
7. Evangelopoulos ME, Weis J, Kruttgen A. 2004. Neurotrophin effects on neuroblastoma cells: correlation with trk and p75NTR expression and influence of Trk receptor bodies. J Neurooncol 66:101-110.
8. Evangelopoulos ME, Weis J, Kruttgen A. 2005. Signalling pathways leading to neuroblastoma differentiation after serum withdrawal: HDL blocks neuroblastoma differentiation by inhibition of EGFR. Oncogene 24:3309-3318.
9. Fischer OM, Hart S, Gschwind A, Ullrich A. 2003. EGFR signal transactivation in cancer cells. Biochem Soc Trans 31:1203-1208.
10. Furuchi T, Anderson RG. 1998. Cholesterol depletion of caveolae causes hyperactivation of extracellular signal-related kinase (ERK). J Biol Chem 273:21099-21104.
11. Ghosh PM, Ghosh-Choudhury N, Moyer ML, Mott GE, Thomas CA, Foster BA, Greenberg NM, Kreisberg JI. 1999. Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line. Oncogene 18:4120-4130.
12. Ghosh-Choudhury N, Mandal CC, Choudhury GG. 2007. Statin-induced Ras activation integrates the phosphatidylinositol 3-kinase signal to Akt and MAPK for bone morphogenetic protein-2 expression in osteoblast differentiation. J Biol Chem 282:4983-4993.
13. Goldstein JL, Brown MS. 1990. Regulation of the mevalonate pathway. Nature 343:425-430.
14. Han J, Wang B, Xiao Z, Gao Y, Zhao Y, Zhang J, Chen B, Wang X, Dai J. 2008. Mammalian target of rapamycin (mTOR) is involved in the neuronal differentiation of neural progenitors induced by insulin. Mol Cell Neurosci 39:118-124.
15. Hughes A, Rogers MJ, Idris AI, Crockett JC. 2007. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo. Calcif Tissue Int 81:403-413.
16. Karp I, Behlouli H, Lelorier J, Pilote L. 2008. Statins and cancer risk. Am J Med 121:302-309.
17. Kinsella BT, Maltese WA. 1992. rab GTP-binding proteins with three different carboxyl-terminal cysteine motifs are modified in vivo by 20-carbon isoprenoids. J Biol Chem 267:3940-3945.
18. Kruttgen A, Schneider I, Weis J. 2006. The dark side of the NGF family: neurotrophins in neoplasias. Brain Pathol 16:304-310.
19. Kumar B, Andreatta C, Koustas WT, Cole WC, Edwards-Prasad J, Prasad KN. 2002. Mevastatin induces degeneration and decreases viability of cAMP-induced differentiated neuroblastoma cells in culture by inhibiting proteasome activity, and mevalonic acid lactone prevents these effects. J Neurosci Res 68:627-635.
20. Lambert S, Ameels H, Gniadecki R, Herin M, Poumay Y. 2008. Internalization of EGF receptor following lipid rafts disruption in keratinocytes is delayed and dependent on p38 MAPK activation. J Cell Physiol 217:834-845.
21. Maltese WA, Sheridan KM. 1985. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis. J Cell Physiol 125:540-558.
22. Martin MG, Perga S, Trovo L, Rasola A, Holm P, Rantamaki T, Harkany T, Castren E, Chiara F, Dotti CG. 2008. Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol Biol Cell 19:2101-2112.
23. Matveev SV, Smart EJ. 2002. Heterologous desensitization of EGF receptors and PDGF receptors by sequestration in caveolae. Am J Physiol Cell Physiol 282:C935-C946.
24. Moises T, Dreier A, Flohr S, Esser M, Brauers E, Reiss K, Merken D, Weis J, Kruttgen A. 2007. Tracking TrkA's trafficking: NGF receptor trafficking controls NGF receptor signaling. Mol Neurobiol 35:151-159.
25. Nakagawara A. 2004. Neural crest development and neuroblastoma: the genetic and biological link. Prog Brain Res 146:233-242.
26. Pike LJ, Casey L. 2002. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 41:10315-10322.
27. Prinetti A, Iwabuchi K, Hakomori S. 1999. Glycosphingolipid-enriched signaling domain in mouse neuroblastoma Neuro2a cells. Mechanism of ganglioside-dependent neuritogenesis. J Biol Chem 274:20916-20924.
28. Riboni L, Prinetti A, Bassi R, Caminiti A, Tettamanti G. 1995. A mediator role of ceramide in the regulation of neuroblastoma Neuro2a cell differentiation. J Biol Chem 270:26868-26875.
29. Ringerike T, Blystad FD, Levy FO, Madshus IH, Stang E. 2002. Cholesterol is important in control of EGF receptor kinase activity but EGF receptors are not concentrated in caveolae. J Cell Sci 115:1331-1340.
30. Roepstorff K, Thomsen P, Sandvig K, van Deurs B. 2002. Sequestration of epidermal growth factor receptors in non-caveolar lipid rafts inhibits ligand binding. J Biol Chem 277:18954-18960.
31. Saito A, Saito N, Mol W, Furukawa H, Tsutsumida A, Oyama A, Sekido M, Sasaki S, Yamamoto Y. 2008. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res 18:85-94.
32. Saxena S, Bucci C, Weis J, Kruttgen A. 2005. The small GTPase Rab7 controls the endosomal trafficking and neuritogenic signaling of the nerve growth factor receptor TrkA. J Neurosci 25:10930-10940.
33. Schulz JG, Bosel J, Stoeckel M, Megow D, Dirnagl U, Endres M. 2004. HMG-CoA reductase inhibition causes neurite loss by interfering with geranylgeranylpyrophosphate synthesis. J Neurochem 89:24-32.
34. Segal RA, Greenberg ME. 1996. Intracellular signaling pathways activated by neurotrophic factors. Annu Rev Neurosci 19:463-489.
35. Takebayashi M, Hayashi T, Su TP. 2004. Sigma-1 receptors potentiate epidermal growth factor signaling towards neuritogenesis in PC12 cells: potential relation to lipid raft reconstitution. Synapse 53:90-103.
36. Traverse S, Seedorf K, Paterson H, Marshall CJ, Cohen P, Ullrich A. 1994. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Curr Biol 4:694-701.
37. Vincent TS, Wulfert E, Merler E. 1991. Inhibition of growth factor signaling pathways by lovastatin. Biochem Biophys Res Commun 180:1284-1289.
38. Wali VB, Sylvester PW. 2007. Synergistic antiproliferative effects of gamma-tocotrienol and statin treatment on mammary tumor cells. Lipids 42:1113-1123.
39. Westover EJ, Covey DF, Brockman HL, Brown RE, Pike LJ. 2003. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J Biol Chem 278:51125-51133.
40. Wu H, Lu D, Jiang H, Xiong Y, Qu C, Li B, Mahmood A, Zhou D, Chopp M. 2008. Simvastatin-mediated upregulation of VEGF and BDNF, activation of the PI3K/Akt pathway, and increase of neurogenesis are associated with therapeutic improvement after traumatic brain injury. J Neurotrauma 25:130-139.